1.86BMarket Cap
LossP/E TTM
URGN Balance Sheet
You can check out the annual or quarterly balance sheets of Urogen Pharma Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing URGN stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Urogen Pharma Ltd Have?
In its most recent quarterly, Urogen Pharma Ltd had 109.97M in cash and cash equivalents.
How Much Are Urogen Pharma Ltd's Total Liabilities?
Urogen Pharma Ltd reported 305.93M in total liabilities as of the latest reported quarter, including 46.42M in current liabilities and 259.51M in non-current liabilities.
What Are Urogen Pharma Ltd's Total Assets?
As of the latest reported quarter, Urogen Pharma Ltd's total assets were 200.46M, consisting of 186.02M in current assets and 14.43M in non-current assets.
How Much Shareholders' Equity Does Urogen Pharma Ltd Have?
Urogen Pharma Ltd reported -105.47M in total shareholders' equity as of the latest reported quarter.